Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Early Intervention, Educational × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Lung Neoplasms 10 Colorectal Neoplasms 9 Prostatic Neoplasms 6 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Hematologic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Skin Carcinoma 2 Pancreatic Neoplasms 2 Neoplasms 2 Lymphoma 2 Hematopoietic and Lymphatic System Neoplasm 2 Breast Carcinoma In Situ 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Pyloric Stenosis, Hypertrophic 1 Prostate 1 Papillomavirus Infections 1 Pain 1 Overweight 1 Obesity 1 Malignant Solid Neoplasm 1 Inflammatory Breast Neoplasms 1 Hematopoietic and Lymphoid System Neoplasm 1 Glioblastoma 1 Genital Neoplasms, Female 1

Interventions

Rituximab 21 Cyclophosphamide 11 Lenalidomide 9 zanubrutinib 7 venetoclax 6 orelabrutinib 6 obinutuzumab 6 fludarabine 6 pirtobrutinib 4 fludarabine phosphate 4 Vincristine 4 Prednisone 4 Magnetic Resonance Spectroscopy 4 CT-P10 4 Bendamustine Hydrochloride 4 ibrutinib 3 Whole-Body Irradiation 3 Specimen Handling 3 Doxorubicin 3 acalabrutinib 2 Radiation 2 Mycophenolic Acid 2 Maintenance 2 Cyclosporine 2 Biopsy 2 voruciclib 1 umbralisib 1 treosulfan 1 tislelizumab 1 tafasitamab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡